MENU
+Compare
CZMWF
Stock ticker: OTC
AS OF
Jan 12 closing price
Price
$48.05
Change
-$1.94 (-3.88%)
Capitalization
4.2B

CZMWF Carl Zeiss Meditec AG Forecast, Technical & Fundamental Analysis

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery... Show more

CZMWF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CZMWF with price predictions
Jan 14, 2026

CZMWF in downward trend: 10-day moving average moved below 50-day moving average on December 11, 2025

The 10-day moving average for CZMWF crossed bearishly below the 50-day moving average on December 11, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CZMWF as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CZMWF moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZMWF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CZMWF's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for CZMWF just turned positive on December 29, 2025. Looking at past instances where CZMWF's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CZMWF advanced for three days, in of 14 cases, the price rose further within the following month. The odds of a continued upward trend are .

CZMWF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.707) is normal, around the industry mean (11.855). P/E Ratio (25.638) is within average values for comparable stocks, (164.317). Projected Growth (PEG Ratio) (0.912) is also within normal values, averaging (2.551). Dividend Yield (0.014) settles around the average of (0.017) among similar stocks. P/S Ratio (1.622) is also within normal values, averaging (113.456).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CZMWF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CZMWF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CZMWF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

CZMWF paid dividends on June 01, 2021

Carl Zeiss Meditec AG CZMWF Stock Dividends
А dividend of $0.50 per share was paid with a record date of June 01, 2021, and an ex-dividend date of May 28, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Goschwitzer Strasse 51-52
Phone
+49 3641220115
Employees
4823
Web
https://www.zeiss.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOMAX16.660.14
+0.85%
Edgar Lomax Value
TCSEX19.160.06
+0.31%
Nuveen Quant Small Cap Equity A
NCLEX26.340.06
+0.23%
Nicholas Limited Edition I
LMCSX34.620.07
+0.20%
Lord Abbett Mid Cap Stock R4
RRGSX93.89-1.36
-1.43%
T. Rowe Price Growth Stock R

CZMWF and Stocks

Correlation & Price change

A.I.dvisor tells us that CZMWF and CZMWY have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZMWF and CZMWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWF
1D Price
Change %
CZMWF100%
N/A
CZMWY - CZMWF
23%
Poorly correlated
-2.73%
SMMNY - CZMWF
20%
Poorly correlated
+0.59%
FONR - CZMWF
20%
Poorly correlated
+0.05%
CLPBY - CZMWF
17%
Poorly correlated
-0.11%
CLPBF - CZMWF
12%
Poorly correlated
N/A
More

Groups containing CZMWF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CZMWF
1D Price
Change %
CZMWF100%
N/A
Pharmaceuticals
category (383 stocks)
10%
Poorly correlated
+0.34%
Pharmaceuticals: Other
category (106 stocks)
7%
Poorly correlated
-0.09%